Evaluation of real-world implementation of HER2 testing showed that uptake was high (>90%) and trastuzumab treatment was targeted to patients with positive HER2 status.
Erin J. Aiello Bowles, MPH
Advertisement
Articles by Erin J. Aiello Bowles, MPH
Woman-level characteristics such as breast symptoms at mammography are associated with earlier follow-up within an integrated health system with an active breast health plan.
Advertisement
Latest Updated Articles
- Timing of Follow-up After Abnormal Screening and Diagnostic Mammograms
Published: March 4th 2011 | Updated:
- Utilization of HER2 Genetic Testing in a Multi-Institutional Observational Study
Published: November 20th 2012 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Trump Administration Flags Potential Link Between Prenatal Acetaminophen Use, Autism
2
Childhood Cancer Awareness Month Spotlights Barriers That Persist in Care
3
More Effective CKD Strategy Could Have Health, Societal Benefits
4
Nicotinamide Reduces New Skin Cancer Risk in Large Veteran Study
5
